Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100:1868–75.

Article  PubMed  Google Scholar 

Saps M, Seshadri R, Sztainberg M, Schaffer G, Marshall BM, Di Lorenzo C. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr. 2009;154:322–6.

Article  PubMed  Google Scholar 

Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology. 2016. https://doi.org/10.1053/j.gastro.2016.02.015.

Article  PubMed  Google Scholar 

Walker LS, Lipani TA, Greene JW, Caines K, Stutts J, Polk DB, et al. Recurrent abdominal pain: symptom subtypes based on the Rome II criteria for pediatric functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2004;38:187–91.

PubMed  Google Scholar 

Schurman JV, Friesen CA, Danda CE, Andre L, Welchert E, Lavenbarg T, et al. Diagnosing functional abdominal pain with Rome II criteria: parent, child, and clinician agreement. J Pediatr Gastroenterol Nutr. 2005;41:291–5.

Article  PubMed  Google Scholar 

Du L, Chen B, Kim JJ, Chen X, Dai N. Micro-inflammation in functional dyspepsia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2018;30: e13304.

Article  CAS  PubMed  Google Scholar 

Friesen CA, Lin Z, Singh M, Singh V, Schurman JV, Burchell N, et al. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci. 2008;53:2634–40.

Article  PubMed  Google Scholar 

Song S, Song Y, Zhang H, Li G, Li X, Wang X, et al. Increased counts and degranulation of duodenal mast cells and eosinophils in functional dyspepsia: a clinical study. Med Glas (Zenica). 2015;12:107.

PubMed  Google Scholar 

Wang X, Li X, Ge W, Huang J, Li G, Cong Y, et al. Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia. Ann Diagn Pathol. 2015;19:50–6.

Article  PubMed  Google Scholar 

Du L, Shen J, Kim JJ, Yu Y, Ma L, Dai N. Increased duodenal eosinophil degranulation in patients with functional dyspepsia: a prospective study. Sci Rep. 2016;6:34305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friesen CA, Andre L, Garola R, Hodge C, Roberts C. Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr. 2002;35:329–33.

PubMed  Google Scholar 

Yuan HP, Li Z, Zhang Y, Li XP, Li FK, Li YQ. Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia. Int J Clin Exp Med. 2015;8:8010–4.

PubMed  PubMed Central  Google Scholar 

Vanheel H, Vicario M, Boesmans W, Vanuytsel T, Salvo-Romero E, Tack J, Farré R. Activation of eosinophils and mast cells in functional dyspepsia: an ultrastructural evaluation. Sci Rep. 2018;8:5383.

Article  PubMed  PubMed Central  Google Scholar 

Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Eosinophils activate mast cells to release histamine. Int Arch Allergy Immunol. 1999;118:202–3.

Article  CAS  PubMed  Google Scholar 

Woodruff SA, Masterson JC, Fillon S, Robinson ZD, Furuta GT. Role of eosinophils in inflammatory bowel disease and gastrointestinal diseases. J Pediatr Gastroenterol Nutr. 2011;52:650–61.

Article  CAS  PubMed  Google Scholar 

Ochi H, De Jesus NH, Hsieh FH, Austen KF, Boyce JA. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci USA. 2000;97:10509–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santos J, Alonso C, Guilarte M, Vicario M, Malagelada JR. Targeting mast cells in the treatment of functional gastrointestinal disorders. Curr Opin Pharmacol. 2006;6:541–6.

Article  CAS  PubMed  Google Scholar 

Schurman JV, Singh M, Singh V, Neilan N, Friesen CA. Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr. 2010;51:298–303.

Article  PubMed  Google Scholar 

Cirillo C, Bessissow T, Desmet AS, Vanheel H, Tack J, Vanden BP. Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia. Am J Gastroenterol. 2015;110:1205–15.

Article  CAS  PubMed  Google Scholar 

Santos J, Saperas E, Nogueiras C, Mourelle M, Antolín M, Cadahia A, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998;114:640–8.

Article  CAS  PubMed  Google Scholar 

Coruzzi G, Adami M, Pozzoli C. Role of histamine H4 receptors in the gastrointestinal tract. Front Biosci (Schol Ed). 2012;4:226–39.

Article  PubMed  Google Scholar 

Wouters MM, Balemans D, Van Wanrooy S, Dooley J, Cibert-Goton V, Alpizar YA, et al. Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology. 2016;150:875–87.

Article  CAS  PubMed  Google Scholar 

Lunardi C, Bambara LM, Biasi D, Cortina P, Peroli P, Nicolis F, et al. Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy. 1991;21:569–72.

Article  CAS  PubMed  Google Scholar 

Stefanini GF, Prati E, Albini MC, Piccinini G, Capelli S, Castelli E, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol. 1992;87:55–7.

CAS  PubMed  Google Scholar 

Stefanini GF, Saggioro A, Alvisi V, Angelini G, Capurso L, di Lorenzo G, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type: multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–41.

Article  CAS  PubMed  Google Scholar 

Friesen CA, Sandridge L, Andre L, Roberts CC, Abdel-Rahman SM. Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr. 2006;45:143–7.

Article  Google Scholar 

Klooker TK, Braak B, Koopman KE, Welting O, Wouters MM, van der Heide S, et al. The mast cell stabilizer ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213–21.

Article  CAS  PubMed  Google Scholar 

Wang J, Zhou H, Gu W, Wang X, Yang J. Effect of ketotifen on gastrointestinal symptoms, visceral sensitivity and intestinal mast cells in patients with irritable bowel syndrome with diarrhea. Chin J Clin Pharm Ther. 2019;24:63–70.

Google Scholar 

Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J. clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol. 2020;32:706–12.

Article  CAS  PubMed  Google Scholar 

Tien FM, Wu JF, Jeng YM, Hsu HY, Ni YH, Chang MH, et al. Clinical features and treatment responses in children with eosinophilic gastroenteritis. Pediatr Neonatol. 2011;52:272–8.

Article  PubMed  Google Scholar 

McFadyen ML, Miller R, Ludden TM. Ketotifen pharmacokinetics in children with atopic perennial asthma. Eur J Clin Pharmacol. 1997;52:383–6.

Article  CAS  PubMed  Google Scholar 

Deacy AD, Gayes LA, De Lurgio S, Wallace DP. Adaptation of the State-Trait Inventory for Cognitive and Somatic Anxiety for use in children: a preliminary analysis. J Pediatr Psychol. 2016;41:1033–43.

Article  PubMed  Google Scholar 

Ree MJ, French D, MacLeod C, Locke V. Distinguishing cognitive and somatic dimensions of state and trait anxiety: development and validation of the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA). Behav Cogn Psychother. 2008;36:313–32.

Article